Daniel Bradbury - Nov 20, 2023 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role
Director
Signature
/s/ Frank Stokes, Attorney-in-fact
Stock symbol
CSTL
Transactions as of
Nov 20, 2023
Transactions value $
-$121,330
Form type
4
Date filed
11/22/2023, 04:22 PM
Previous filing
Nov 13, 2023
Next filing
Nov 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSTL Common Stock Sale -$69.2K -3.45K -3.41% $20.04 97.9K Nov 20, 2023 By LLC F1, F2, F3
transaction CSTL Common Stock Sale -$23.1K -1.15K -1.77% $20.04 63.9K Nov 20, 2023 By Daniel Bradbury Irrecovable Descendant's Trust F1, F2, F4
transaction CSTL Common Stock Sale -$23.1K -1.15K -1.77% $20.04 63.9K Nov 20, 2023 By Annette Bradbury Irrecovable Descendant's Trust F1, F2, F5
transaction CSTL Common Stock Sale -$3.6K -180 -0.18% $20.00 97.7K Nov 21, 2023 By LLC F1, F3
transaction CSTL Common Stock Sale -$1.2K -60 -0.09% $20.00 63.8K Nov 21, 2023 By Daniel Bradbury Irrecovable Descendant's Trust F1, F4
transaction CSTL Common Stock Sale -$1.2K -60 -0.09% $20.00 63.9K Nov 21, 2023 By Annette Bradbury Irrecovable Descendant's Trust F1, F5
holding CSTL Common Stock 4.66K Nov 20, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $20.00 to $20.11, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F4 Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F5 Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.